PILGRIM - Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus Type II

Trial Profile

PILGRIM - Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus Type II

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Insulin aspart (Primary) ; Liraglutide (Primary) ; Glucose; Insulin; Potassium chloride
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms PILGRIM
  • Most Recent Events

    • 23 Jan 2017 Status changed from recruiting to completed.
    • 08 Aug 2016 Planned number of patients changed from 315 to 150.
    • 05 Feb 2016 Planned End Date changed from 1 Mar 2016 to 1 Mar 2017 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top